Vivos Therapeutics Inc
NASDAQ:VVOS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for Vivos Therapeutics Inc.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Vivos Therapeutics Does
Vivos Therapeutics, Inc. is a medical technology company which engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing (SDB). The company is headquartered in Littleton, Colorado and currently employs 268 full-time employees. The company went IPO on 2020-12-11. The firm's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA…
- Headquarters
- United States of America US
- Employees
- 270
- IPO date
- Dec 11, 2020
Balance Sheet
Recent Events
Latest Earnings Call
Vivos is shifting toward integrated sleep-care services and payer improvements, while tight liquidity and Nasdaq bid-price compliance remain key execution risks.
Open the earnings call- EPS
- −$0.07
- Expected
- −$0.30
- Surprise
- +76.7%
- Stock, next trading day
- −3.0%
Vivos Therapeutics insiders are buying more than usual
Past 12 months
Continue VVOS Research
Decided on Vivos Therapeutics? Get an email when VVOS reaches the price you’d buy at. Free with an account.